Dyadic International, Inc.: Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress

Commercial launch of AlbuFree DX recombinant human albumin by Proliant Health & Biologicals using Dyadic's production platform, with Dyadic eligible to receive a share of profits from product salesExp ...
The Manila Times

Dyadic Announces 2025 Financial Results and Highlights Recent Company Progress

Commercial launch of AlbuFree™ DX recombinant human albumin by Proliant Health & Biologicals using Dyadic’s production ...

Competent Cells Market Size to Reach USD 7.06 Billion by 2035, Driven by Synthetic Biology Expansion and Advanced Gene Editing Workflows – SNS Insider

Rising demand for recombinant proteins, automation-ready cloning workflows, and AI-integrated molecular biology kits accelerates market growth at a CAGR of 10.68%.Austin, United States, March 25, 2026 ...
Labroots

Confident protein validation: The power of SDS-PAGE and Western blot in ÄKTA™ chromatography workflow

In academic and industrial protein research, speed, accuracy, and accessibility are essential. After purifying proteins using ...